Skip to main content Skip to page footer

Myelodysplastic Syndrome (MDS)

Logo des NCT Heidelberg Logo des NCT Heidelberg

Myelodysplastic Syndrome (MDS)

Recruiting after consultation
Open recruiting

First line therapy

There are currently no studies available

Follow-up therapy

Title: A Modular Phase I/II, Open-label, Multi-Centre Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants with Advanced Haematologic Malignancies with KMT2Ar, NPM1m, or Other Genotypes Associated with HOX Overexpression
Phase: I/II
Contact: Melanie Bauer / Kontaktperson
Email-Address: Melanie.Bauer3(at)med.uni-heidelberg.de
Clinical Investigator: Dr. med. Tim Sauer
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT07155226
EU CTIS/EudraCT: Die Studie ist im EU-CTIS registriert. CTIS: 2025-521299-76-00

Surgical Study

There are currently no studies available

Radiotherapy Study

There are currently no studies available

Other study

Title: Zentrale Registrierung von Patientendaten und Biomaterialbank bei Aplastischen Anämien und Bone Marrow Failure Syndromen AA-BMF-Register
Phase: N/A
Contact: Martina Gronkowski / Kontaktperson
Email-Address: Martina.Gronkowski(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Thomas Luft
Registration: Keine Registernummer angegeben.
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A:

Title: IMPULS-A: Implementierung eines Unterstützungsprogramms für Langzeitkrebsüberlebende im Alter
Phase: N/A
Contact: M. Sc. Charlotte Flock / Kontaktperson
Email-Address: IMPULS-A(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Hans-Christoph Friederich
Registration: Keine Registernummer angegeben.
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A:

Title: Randomized Comparison of Treatment Guided by Comprehensive Genome and Transcriptome Analysis Versus Standard of Care in Patients With Advanced Rare Cancers (RATIONALE)
Phase: N/A
Contact: Elke Bauriegel / Kontaktperson
Email-Address: rationale_pm(at)nct-heidelberg.de
Clinical Investigator: Prof. Dr. med. Richard Schlenk
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT06855134
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A:

Title: NCT MASTER Plattform Molecularly Aided Stratification for Tumor Eradication Research
Phase: N/A
Contact: MASTER Studienbüro / Kontaktperson
Email-Address: master(at)nct-heidelberg.de
Clinical Investigator: Prof. Dr. med. Stefan Fröhling
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT05852522
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A: